Synopsys (NASDAQ:SNPS – Get Free Report) is projected to post its Q2 2025 quarterly earnings results after the market closes on Wednesday, May 28th. Analysts expect Synopsys to post earnings of $3.39 per share and revenue of $1.60 billion for the quarter.
Synopsys Trading Down 0.1%
SNPS stock opened at $515.61 on Wednesday. The company has a market cap of $79.72 billion, a price-to-earnings ratio of 35.51, a PEG ratio of 3.23 and a beta of 1.16. Synopsys has a 12 month low of $365.74 and a 12 month high of $624.80. The firm has a 50-day moving average of $447.85 and a two-hundred day moving average of $489.13.
Insider Activity
In related news, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the transaction, the chief executive officer now owns 70,922 shares of the company’s stock, valued at approximately $32,890,077.50. This trade represents a 13.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Geus Aart De sold 15,705 shares of the stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the transaction, the insider now directly owns 116,671 shares of the company’s stock, valued at $51,850,925.82. The trade was a 11.86% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.62% of the company’s stock.
Hedge Funds Weigh In On Synopsys
Analyst Ratings Changes
A number of research firms have commented on SNPS. Wells Fargo & Company cut their price objective on shares of Synopsys from $540.00 to $520.00 and set an “equal weight” rating for the company in a report on Thursday, February 27th. KeyCorp increased their price objective on shares of Synopsys from $555.00 to $575.00 and gave the company an “overweight” rating in a report on Tuesday. Morgan Stanley cut their price objective on shares of Synopsys from $625.00 to $590.00 and set an “overweight” rating for the company in a report on Monday, February 24th. Piper Sandler cut their price objective on shares of Synopsys from $655.00 to $653.00 and set an “overweight” rating for the company in a report on Thursday, February 27th. Finally, Stifel Nicolaus set a $550.00 price objective on shares of Synopsys in a report on Monday, April 28th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, Synopsys currently has a consensus rating of “Moderate Buy” and a consensus target price of $614.86.
Read Our Latest Stock Analysis on SNPS
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
- Five stocks we like better than Synopsys
- Upcoming IPO Stock Lockup Period, Explained
- Top 5 Stocks Hedge Funds Are Buying Right Now
- How to Calculate Return on Investment (ROI)
- Viking Holdings Posts Strong Q1, Eyes Growth Ahead
- About the Markup Calculator
- 2 Reasons Netflix’s 40% Rally Is Far From Over
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.